Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,622 | 51,617 | 99,107 | 95,607 | 114,582 |
| Receivables | 778,638 | 670,476 | 614,687 | 692,550 | 674,885 |
| Inventories | 575,624 | 570,653 | 581,384 | 576,474 | 550,558 |
| TOTAL | $1,485,480 | $1,380,044 | $1,377,863 | $1,456,075 | $1,421,789 |
| Non-Current Assets | |||||
| PPE Net | 425,380 | 439,815 | 447,574 | 451,852 | 459,108 |
| Intangibles | 1,418,477 | 1,457,821 | 1,489,052 | 1,581,162 | 1,614,582 |
| Other Non-Current Assets | 180,585 | 178,717 | 158,080 | 197,990 | 205,407 |
| TOTAL | $2,024,442 | $2,076,353 | $2,094,706 | $2,231,004 | $2,279,097 |
| Total Assets | $3,509,922 | $3,456,397 | $3,472,569 | $3,687,079 | $3,700,886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 435,519 | 212,660 | 213,125 | 106,533 | 150,405 |
| Accounts payable and accrued liabilities | 631,967 | 575,593 | 541,983 | 561,261 | 533,862 |
| Other current liabilities | 30,740 | 30,130 | 76,988 | 76,828 | 77,011 |
| TOTAL | $1,114,353 | $834,388 | $846,595 | $760,601 | $777,350 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,177,578 | 2,419,600 | 2,427,451 | 2,582,815 | 2,589,737 |
| Other Non-Current Liabilities | 264,687 | 256,073 | 173,207 | 174,076 | 165,265 |
| TOTAL | $2,453,058 | $2,685,638 | $2,605,963 | $2,772,242 | $2,772,768 |
| Total Liabilities | $3,567,411 | $3,520,026 | $3,452,558 | $3,532,843 | $3,550,118 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 309,543 | 308,651 | 307,007 | 306,544 | 306,312 |
| Common Shares | 3,095 | 3,086 | 3,066 | 3,064 | 3,062 |
| Retained earnings | -575,825 | -581,819 | -490,176 | -391,527 | -401,209 |
| Other shareholders' equity | -30,460 | -23,616 | -32,119 | -172,751 | -159,318 |
| TOTAL | $-57,489 | $-63,629 | $20,011 | $154,236 | $150,768 |
| Total Liabilities And Equity | $3,509,922 | $3,456,397 | $3,472,569 | $3,687,079 | $3,700,886 |